KIMO 財務： Kimo Inc AI 分析

首頁

股票

KIMO

財務狀況

KIMO 財務

Kimo Inc

$0.33

收盤價：Mar 27, 16:00:00 GMT-4

$0.33

盤後：Mar 27, 20:00:00 GMT-4

概觀預測收益股利財務狀況

收入

資產負債表

現金流量

年度

每季

KIMO 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
營收	59	51	9	6	5	5
營收年增率 (YoY)	883%	467%	50%	20%	0%	-28.99%
營收成本	1	0	0	0	0	0
毛利	58	50	8	5	5	4
銷售、一般及管理費用	11	11	7	7	7	8
研發	12	12	12	11	10	15
營業費用	23	24	20	18	18	23
其他非營業收入 (費用)	0	0	0	0	0	0
稅前淨利	30	21	-16	-17	-14	-19
所得稅費用	5	5	0	0	0	1
淨利	25	15	-16	-17	-14	-20
淨利成長	-239%	-194%	-6%	21%	-30%	0%
稀釋後流通股數	19.96	18.56	17.84	17.84	17.84	17.84
股數年變動 (YoY)	8%	4%	0%	0%	0%	0%
每股盈餘 (稀釋)	1.26	0.85	-0.9	-0.98	-0.83	-1.17
每股盈餘成長率	-225%	-194%	-7%	17%	-28.99%	4%
自由現金流	24	-17	-10	-11	-11	-15
每股自由現金流	--	--	--	--	--	--
毛利率	98.3%	98.03%	88.88%	83.33%	100%	80%
營業利益率	59.32%	50.98%	-122.22%	-216.66%	-240%	-360%
淨利率	42.37%	29.41%	-177.77%	-283.33%	-280%	-400%
自由現金流利潤率	40.67%	-33.33%	-111.11%	-183.33%	-220%	-300%
EBITDA	35	26	-11	-13	-12	-18
EBITDA 利潤率	59.32%	50.98%	-122.22%	-216.66%	-240%	-360%
EBITDA 中的折舊與攤銷	0	0	0	0	0	0
EBIT	35	26	-11	-13	-12	-18
EBIT 利潤率	59.32%	50.98%	-122.22%	-216.66%	-240%	-360%
有效稅率	16.66%	23.8%	0%	0%	0%	-5.26%

Follow-Up Questions

Kimo Inc 的關鍵財務報表是什麼？



根據最新的財務報表（Form-10K），Newron Pharmaceuticals SpA 的總資產為 $63，淨isProfitable}為 $15

KIMO 的關鍵財務比率是什麼？



Newron Pharmaceuticals SpA 的流動比率為 1.01，淨利潤率為 29.41，每股銷售為 $2.74。

Kimo Inc 的收入按細分市場或地理位置如何劃分？



Newron Pharmaceuticals SpA 最大收入來源為 Pharmaceutical Drugs，在最近的收益報告中收入為 8,799,296。就地區而言，Italy & United States 是 Newron Pharmaceuticals SpA 的主要市場，收入為 8,799,296。

Kimo Inc 是否盈利？



是的，根據最新的財務報表，Newron Pharmaceuticals SpA 的淨利潤為 $15

Kimo Inc 有負債嗎？



是的，Newron Pharmaceuticals SpA 的負債為 62

Kimo Inc 的流通股有多少？



Newron Pharmaceuticals SpA 的總流通股為 19.95

關鍵數據

前收市價

$0.33

開盤價

$0.9

當日範圍

$0.33 - $0.9

52週區間

$0.33 - $0.9

交易量

1.0K

平均成交量

股息收益率

每股盈餘 (TTM)

市值

$8.8M

什麼是 KIMO？

Kimo, Inc. engages in manufacturing, distilling, refining, and creating beverages based on spirit and non-alcoholic. The company is headquartered in Huntington Beach, California. The company went IPO on 2024-01-26. The firm is engaged in distilling, refining, and creating beverages, both spirit-based and non-alcoholic. Its Kimo Spirits portfolio is home to Kimo Sabe Mezcal, Trusted Friend Cocktails, Surf City Still Works, Aga-Vie, and Dr’s Honeymilk. Trusted Friend Cocktails are a collaboration of Surf City Still Works and Kimo Sabe. The firm's portfolio includes Surf City Still Works LLC, Beverage Ventures Inc, and DWLL Inc. In addition, the Company has a wholly owned foreign entity, Kimo Sabe SAPI de CV. Beverage Ventures Inc is a specialty retail supplier offering a blend of Tequila and French Cognac. DWLL Inc is a global distributor and brand marketer of spirits products.

功能特性

資源